The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health ...
Aug 11, 2014
5 / 5 (1) | 0
As the deadliest Ebola outbreak in history tightens its grip on west Africa, pharmaceutical companies have refocused their quest for a treatment or vaccine.
Aug 12, 2014
not rated yet | 0